How to Source Lomitapide for Pharmaceutical Formulation
Lomitapide (Capsules, 5 mg, 10 mg, 20 mg, 30 mg) is classified under Heart Disorder. It is therapeutically aligned with reference brands such as Juxtapid(USA), Lojuxta(EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Lomitapide for formulation, R&D, or bulk manufacturing.
Product Overview:
Lomitapide is a microsomal triglyceride transfer protein (MTP) inhibitor used to lower LDL cholesterol in adults with homozygous familial hypercholesterolemia (HoFH). It decreases lipoprotein assembly in the liver, leading to reduced LDL, total cholesterol, and non-HDL cholesterol.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Lomitapide must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Lomitapide is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Conclusion
Sourcing Lomitapide is more than procurement—it’s a strategic partnership. With its capsules form and 5 mg, 10 mg, 20 mg, 30 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Lomitapide.
Frequently Asked Questions For Sourcing of Lomitapide
What is the typical lead time for Lomitapide?
Lead times range from 4–6 weeks depending on supplier and region.
Is Lomitapide available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Lomitapide require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Lomitapide?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Lomitapide?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Lomitapide?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Lomitapide suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Lomitapide be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
Advertise on PharmaTradZ
Reach verified pharma buyers, suppliers & decision makers worldwide.
Explore Pharma Investment Opportunities
Connect with partners, startups & ventures driving the future of pharma.